175
Participants
Start Date
December 31, 2001
Primary Completion Date
November 30, 2004
Study Completion Date
November 30, 2004
Alefacept
intramuscular injection (IM)
Liège
Washington D.C.
Besançon
Madrid
Brest
Newnan
Jacksonville
Pinellas Park
Tours
Goodlettsville
Bochum
Valencia
Clinton Township
Chicago
St Louis
Kansas City
Omaha
Hot Springs
Paris
San Antonio
Austin
Lake Oswego
Munich
La Jolla
Fresno
Portland
Berlin
Johnston
Brussels
Edegem
Calgary
Winnipeg
Moncton
St. John's
London
Waterloo
Windsor
Sainte-Foy
Copenhagen
Nice
Dresden
Amsterdam
Liverpool
Lead Sponsor
Collaborators (1)
Biogen
INDUSTRY
Astellas Pharma Inc
INDUSTRY